HEALTH CATALYST INC (HCAT) Stock Price, Quote, News and Overview
NASDAQ:HCAT - Nasdaq - US42225T1079 - Common Stock - Currency: USD
HCAT Quote, Performance and Key Statistics
NASDAQ:HCAT (6/10/2025, 12:15:53 PM)
4.175
+0.01 (+0.36%)
The current stock price of HCAT is 4.175 USD. In the past month the price increased by 0.73%. In the past year, price decreased by -35.6%.
HCAT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 40.1 | 46.26B | ||
| DOCS | DOXIMITY INC-CLASS A | 41.47 | 10.98B | ||
| WAY | WAYSTAR HOLDING CORP | 51.56 | 7.05B | ||
| CERT | CERTARA INC | 24.82 | 1.97B | ||
| SDGR | SCHRODINGER INC | N/A | 1.93B | ||
| PHR | PHREESIA INC | N/A | 1.66B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 13.1 | 1.59B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.30B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| EVH | EVOLENT HEALTH INC - A | 23.16 | 1.03B | ||
| HSTM | HEALTHSTREAM INC | 44.68 | 859.42M | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 798.58M |
Related stock screener links
About HCAT
Company Profile
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.
Company Info
HEALTH CATALYST INC
10897 South River Front Parkway, #300
South Jordan UTAH 84121 US
CEO: Daniel Burton
Employees: 1500
Phone: 18017086800
HEALTH CATALYST INC / HCAT FAQ
What is the stock price of HEALTH CATALYST INC today?
The current stock price of HCAT is 4.175 USD. The price increased by 0.36% in the last trading session.
What is the ticker symbol for HEALTH CATALYST INC stock?
The exchange symbol of HEALTH CATALYST INC is HCAT and it is listed on the Nasdaq exchange.
On which exchange is HCAT stock listed?
HCAT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for HEALTH CATALYST INC stock?
19 analysts have analysed HCAT and the average price target is 8.16 USD. This implies a price increase of 95.45% is expected in the next year compared to the current price of 4.175. Check the HEALTH CATALYST INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HEALTH CATALYST INC worth?
HEALTH CATALYST INC (HCAT) has a market capitalization of 290.58M USD. This makes HCAT a Micro Cap stock.
How many employees does HEALTH CATALYST INC have?
HEALTH CATALYST INC (HCAT) currently has 1500 employees.
What are the support and resistance levels for HEALTH CATALYST INC (HCAT) stock?
HEALTH CATALYST INC (HCAT) has a support level at 4.13 and a resistance level at 4.17. Check the full technical report for a detailed analysis of HCAT support and resistance levels.
Is HEALTH CATALYST INC (HCAT) expected to grow?
The Revenue of HEALTH CATALYST INC (HCAT) is expected to grow by 9.06% in the next year. Check the estimates tab for more information on the HCAT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HEALTH CATALYST INC (HCAT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HCAT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HCAT, evaluating the profitability, health, valuation and growth aspects
- HEALTH CATALYST INC (HCAT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HEALTH CATALYST INC (HCAT) Sales and EPS estimates to see what analysts future expectations are.
- HEALTH CATALYST INC (HCAT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HEALTH CATALYST INC (HCAT) Insider and Institutional Ownership to learn about the owners and their transactions.
- HEALTH CATALYST INC (HCAT) Stock Chart to make your own analysis
- HEALTH CATALYST INC (HCAT) Latest news and press-releases to stay up to date.
Does HEALTH CATALYST INC (HCAT) stock pay dividends?
HCAT does not pay a dividend.
When does HEALTH CATALYST INC (HCAT) report earnings?
HEALTH CATALYST INC (HCAT) will report earnings on 2025-08-05, after the market close.
What is the Price/Earnings (PE) ratio of HEALTH CATALYST INC (HCAT)?
The PE ratio for HEALTH CATALYST INC (HCAT) is 17.4. This is based on the reported non-GAAP earnings per share of 0.24 and the current share price of 4.175 USD. Check the full fundamental report for a full analysis of the valuation metrics for HCAT.
What is the Short Interest ratio of HEALTH CATALYST INC (HCAT) stock?
The outstanding short interest for HEALTH CATALYST INC (HCAT) is 4.81% of its float. Check the ownership tab for more information on the HCAT short interest.
HCAT Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to HCAT. When comparing the yearly performance of all stocks, HCAT is a bad performer in the overall market: 84.91% of all stocks are doing better.
HCAT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to HCAT. HCAT has a bad profitability rating. Also its financial health evaluation is rather negative.
HCAT Financial Highlights
Over the last trailing twelve months HCAT reported a non-GAAP Earnings per Share(EPS) of 0.24. The EPS increased by 60% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.15% | ||
| ROE | -19.28% | ||
| Debt/Equity | 0.4 |
HCAT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to HCAT. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 7.17% and a revenue growth 9.06% for HCAT